Robb Gary Charles Insider Trades

Insider Trading History

Track insider trading activity for Robb Gary Charles. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $2.32M 25,681 shares
Last Trade
Jun 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$25.2k 358 shares
$70.44
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $2.36M 26,039 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 1,552 shares
$70.44
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $2.27M 25,081 shares
Last Trade
May 27, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$40k 600 shares
$66.65
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.14M 12,571 shares
Last Trade
May 13, 2026 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$57.1k 1,000 shares
$57.08
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $2.22M 24,487 shares
Last Trade
May 13, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$303k 5,300 shares
$57.08
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $7.19M 79,503 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.35k 121 shares
$35.97
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $7.2M 79,624 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.9k 998 shares
$35.97
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $12.7M 140,000 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 140,000 shares
$35.70
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $14.4M 158,910 shares
Last Trade
Dec 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.1M 145,000 shares
$83.59
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $0 0 shares
Last Trade
Dec 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.1M 145,000 shares
$83.59
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $7.11M 78,626 shares
Last Trade
Dec 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.71M 80,284 shares
$83.59
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.26M 13,910 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.8k 148 shares
$79.78
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.27M 14,058 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.7k 448 shares
$79.78
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.23M 13,610 shares
Last Trade
Sep 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$18.3k 256 shares
$71.38
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.25M 13,866 shares
Last Trade
Sep 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.8k 502 shares
$71.38
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.21M 13,364 shares
Last Trade
Aug 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$190k 2,674 shares
$71.17
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.45M 16,038 shares
Last Trade
Aug 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$166k 2,326 shares
$71.27
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.66M 18,364 shares
Last Trade
Aug 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 5,000 shares
$70.33
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $13.1M 145,000 shares
Last Trade
Aug 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 5,000 shares
$70.33
$90.47
Corcept Therapeutics
Corcept Therapeutics CORT
Chief Business Officer
Holding Value $1.21M 13,364 shares
Last Trade
Jun 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$225k 3,185 shares
$70.77
$90.47

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up